NRC Health Anticipates ~40% Effective Tax Rate in H2 Amidst Strong Q2 Performance and Pipeline Growth
In the second quarter of 2026, NRC Health (NASDAQ:NRC) reported strong execution with an 11% year-over-year increase in total recurring contract value (TRCV). CEO Trent Green highlighted this growth as a reflection of solid performance across diversified areas. The company also noted significant progress in its sales pipeline, which grew by approximately 60%. Looking ahead to the second half of the year, NRC Health expects an effective tax rate of around 40%, signaling potential changes in financial strategy or regulatory environment. The management's confidence is rooted in consistent performance and a robust outlook for future contracts. The anticipated higher tax rate may impact net income but could reflect strategic investments or operational shifts aimed at long-term growth.
Tickers: $NRC
Topics: earnings Q2 performance revenue growth TRCV (Total Recurring Contract Value)